12/4/2020  9:02:20 AM Chg. +0.0200 Volume Bid11:28:46 AM Ask11:28:46 AM Market Capitalization Dividend Y. P/E Ratio
1.2100EUR +1.68% 60
Turnover: 72.6000
1.2100Bid Size: 1,900 1.2300Ask Size: 1,500 29.4 mill.EUR 0.00% -

Business description

The biopharmaceutical company co.don AG based near Berlin is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. The company's patented pharmaceutical products are used to treat cartilage damage. Left untreated, cartilage defects can often result in joint replacement surgery.
 

Management board & Supervisory board

CEO
Tilmann Bur
Management board
-
Supervisory board
Prof. Hans B. Bauerfeind, Thommy Stählin, Beatrix Bauerfeind-Johnson, Prof. Dr. Barbara Sickmüller, Prof. Dr. Hans-Jörg Bullinger, Thomas Krause
 

Company data

Name: Co.don AG
Address: Warthestraße 21,D-14513 Teltow
Phone: +49-3328-4346-0
Fax: +49-3328-4346-43
E-mail: info@codon.de
Internet: www.codon.de
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 48.09%
IPO date: 2/14/2001

Investor relations

Name: Matthias Meißner
IR phone: 49-30-2403-52-330
IR Fax: -
IR e-mail: ir@codon.de

Main Shareholders

Freefloat
 
48.09%
Bauerfeind Beteiligungsgesellschaft mbH
 
37.54%
BBJ Beteiligungsgesellschaft mbH
 
6.90%
Klaus Stuffer
 
4.50%
ALTOINVEST
 
2.97%